Monoclonal Antibody Based Products Market Report

Japan Monoclonal Antibody Based Products Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 23, 2019
  • PAGES：192
  • REPORT CODE：GMM308922
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Monoclonal Antibody Based Products market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Monoclonal Antibody Based Products market. Detailed analysis of key players, along with key growth strategies adopted by Monoclonal Antibody Based Products industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Strategic Diagnostics Inc

    • Immunomedics, Inc.

    • Centocor

    • Ortho Biotech Products, L.P.

    • CMC ICOS Biologices

    • Human Genome Sciences, Inc.

    • Dendreon Inc

    • Genentech, Inc.

    • Schering-Plough Corporation

    • Medarex, Inc.

    • BD Biosciences Corporation

    • PDL BioPharma

    • Biotest, Inc.

    • Johnson & Johnson

    • UCB Group

    • MedImmune, Inc.

    • Eli Lilly and Company

    • Amgen AG

    • Elan Corporations Plc

    • Wyeth Pharmaceuticals

    • CMC ICOS Biologics, Inc.


    By Type:

    • Murine

    • Chimeric

    • Humanized

    • Human


    By End-User:

    • Therapeutics

    • Diagnostics


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal Antibody Based Products Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Murine from 2014 to 2026

      • 1.3.2 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Chimeric from 2014 to 2026

      • 1.3.3 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Humanized from 2014 to 2026

      • 1.3.4 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Human from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Therapeutics from 2014 to 2026

      • 1.4.2 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Monoclonal Antibody Based Products Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Monoclonal Antibody Based Products by Major Types

      • 3.4.1 Market Size and Growth Rate of Murine

      • 3.4.2 Market Size and Growth Rate of Chimeric

      • 3.4.3 Market Size and Growth Rate of Humanized

      • 3.4.4 Market Size and Growth Rate of Human

    4 Segmentation of Monoclonal Antibody Based Products Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Monoclonal Antibody Based Products by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Monoclonal Antibody Based Products in Therapeutics

      • 4.4.2 Market Size and Growth Rate of Monoclonal Antibody Based Products in Diagnostics


    5 Market Analysis by Regions

    • 5.1 Japan Monoclonal Antibody Based Products Production Analysis by Regions

    • 5.2 Japan Monoclonal Antibody Based Products Consumption Analysis by Regions


    6 Hokkaido Monoclonal Antibody Based Products Landscape Analysis

    • 6.1 Hokkaido Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 6.2 Hokkaido Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    7 Tohoku Monoclonal Antibody Based Products Landscape Analysis

    • 7.1 Tohoku Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 7.2 Tohoku Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    8 Kanto Monoclonal Antibody Based Products Landscape Analysis

    • 8.1 Kanto Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 8.2 Kanto Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    9 Chubu Monoclonal Antibody Based Products Landscape Analysis

    • 9.1 Chubu Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 9.2 Chubu Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    10 Kinki Monoclonal Antibody Based Products Landscape Analysis

    • 10.1 Kinki Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 10.2 Kinki Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    11 Chugoku Monoclonal Antibody Based Products Landscape Analysis

    • 11.1 Chugoku Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 11.2 Chugoku Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    12 Shikoku Monoclonal Antibody Based Products Landscape Analysis

    • 12.1 Shikoku Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 12.2 Shikoku Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    13 Kyushu Monoclonal Antibody Based Products Landscape Analysis

    • 13.1 Kyushu Monoclonal Antibody Based Products Landscape Analysis by Major Types

    • 13.2 Kyushu Monoclonal Antibody Based Products Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Strategic Diagnostics Inc

      • 14.1.1 Strategic Diagnostics Inc Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Immunomedics, Inc.

      • 14.2.1 Immunomedics, Inc. Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Centocor

      • 14.3.1 Centocor Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Ortho Biotech Products, L.P.

      • 14.4.1 Ortho Biotech Products, L.P. Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 CMC ICOS Biologices

      • 14.5.1 CMC ICOS Biologices Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Human Genome Sciences, Inc.

      • 14.6.1 Human Genome Sciences, Inc. Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Dendreon Inc

      • 14.7.1 Dendreon Inc Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Genentech, Inc.

      • 14.8.1 Genentech, Inc. Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Schering-Plough Corporation

      • 14.9.1 Schering-Plough Corporation Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Medarex, Inc.

      • 14.10.1 Medarex, Inc. Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 BD Biosciences Corporation

      • 14.11.1 BD Biosciences Corporation Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 PDL BioPharma

      • 14.12.1 PDL BioPharma Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Biotest, Inc.

      • 14.13.1 Biotest, Inc. Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Johnson & Johnson

      • 14.14.1 Johnson & Johnson Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 UCB Group

      • 14.15.1 UCB Group Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 MedImmune, Inc.

      • 14.16.1 MedImmune, Inc. Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Eli Lilly and Company

      • 14.17.1 Eli Lilly and Company Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Amgen AG

      • 14.18.1 Amgen AG Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 Elan Corporations Plc

      • 14.19.1 Elan Corporations Plc Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

    • 14.20 Wyeth Pharmaceuticals

      • 14.20.1 Wyeth Pharmaceuticals Company Profile and Recent Development

      • 14.20.2 Market Performance

      • 14.20.3 Product and Service Introduction

    • 14.21 CMC ICOS Biologics, Inc.

      • 14.21.1 CMC ICOS Biologics, Inc. Company Profile and Recent Development

      • 14.21.2 Market Performance

      • 14.21.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 95 Figures and 131 Tables)

     

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Murine from 2014 to 2026

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Chimeric from 2014 to 2026

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Humanized from 2014 to 2026

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Human from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Therapeutics from 2014 to 2026

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Monoclonal Antibody Based Products Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Monoclonal Antibody Based Products

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Monoclonal Antibody Based Products by Different Types from 2014 to 2026

    • Table Consumption Share of Monoclonal Antibody Based Products by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Murine

    • Figure Market Size and Growth Rate of Chimeric

    • Figure Market Size and Growth Rate of Humanized

    • Figure Market Size and Growth Rate of Human

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Monoclonal Antibody Based Products by Different End-Users from 2014 to 2026

    • Table Consumption Share of Monoclonal Antibody Based Products by Different End-Users from 2014 to 2026

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Therapeutics from 2014 to 2026

    • Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • Table Japan Monoclonal Antibody Based Products Production by Regions

    • Table Japan Monoclonal Antibody Based Products Production Share by Regions

    • Figure Japan Monoclonal Antibody Based Products Production Share by Regions in 2014

    • Figure Japan Monoclonal Antibody Based Products Production Share by Regions in 2018

    • Figure Japan Monoclonal Antibody Based Products Production Share by Regions in 2026

    • Table Japan Monoclonal Antibody Based Products Consumption by Regions

    • Table Japan Monoclonal Antibody Based Products Consumption Share by Regions

    • Figure Japan Monoclonal Antibody Based Products Consumption Share by Regions in 2014

    • Figure Japan Monoclonal Antibody Based Products Consumption Share by Regions in 2018

    • Figure Japan Monoclonal Antibody Based Products Consumption Share by Regions in 2026

    • Table Hokkaido Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Hokkaido Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Hokkaido Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Tohoku Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Tohoku Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Tohoku Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Tohoku Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Tohoku Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Kanto Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Kanto Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Kanto Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Kanto Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Kanto Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Kanto Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Kanto Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Kanto Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Kanto Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Chubu Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Chubu Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Chubu Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Chubu Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Chubu Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Chubu Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Chubu Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Chubu Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Chubu Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Kinki Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Kinki Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Kinki Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Kinki Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Kinki Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Kinki Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Kinki Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Kinki Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Kinki Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Chugoku Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Chugoku Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Chugoku Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Chugoku Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Chugoku Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Shikoku Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Shikoku Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Shikoku Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Shikoku Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Shikoku Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Kyushu Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026

    • Table Kyushu Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Monoclonal Antibody Based Products Consumption Share by Types in 2014

    • Figure Kyushu Monoclonal Antibody Based Products Consumption Share by Types in 2018

    • Figure Kyushu Monoclonal Antibody Based Products Consumption Share by Types in 2026

    • Table Kyushu Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026

    • Table Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users in 2014

    • Figure Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users in 2018

    • Figure Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Strategic Diagnostics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Strategic Diagnostics Inc

    • Figure Sales and Growth Rate Analysis of Strategic Diagnostics Inc

    • Figure Revenue and Market Share Analysis of Strategic Diagnostics Inc

    • Table Product and Service Introduction of Strategic Diagnostics Inc

    • Table Company Profile and Development Status of Immunomedics, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc.

    • Figure Sales and Growth Rate Analysis of Immunomedics, Inc.

    • Figure Revenue and Market Share Analysis of Immunomedics, Inc.

    • Table Product and Service Introduction of Immunomedics, Inc.

    • Table Company Profile and Development Status of Centocor

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Centocor

    • Figure Sales and Growth Rate Analysis of Centocor

    • Figure Revenue and Market Share Analysis of Centocor

    • Table Product and Service Introduction of Centocor

    • Table Company Profile and Development Status of Ortho Biotech Products, L.P.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ortho Biotech Products, L.P.

    • Figure Sales and Growth Rate Analysis of Ortho Biotech Products, L.P.

    • Figure Revenue and Market Share Analysis of Ortho Biotech Products, L.P.

    • Table Product and Service Introduction of Ortho Biotech Products, L.P.

    • Table Company Profile and Development Status of CMC ICOS Biologices

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CMC ICOS Biologices

    • Figure Sales and Growth Rate Analysis of CMC ICOS Biologices

    • Figure Revenue and Market Share Analysis of CMC ICOS Biologices

    • Table Product and Service Introduction of CMC ICOS Biologices

    • Table Company Profile and Development Status of Human Genome Sciences, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Human Genome Sciences, Inc.

    • Figure Sales and Growth Rate Analysis of Human Genome Sciences, Inc.

    • Figure Revenue and Market Share Analysis of Human Genome Sciences, Inc.

    • Table Product and Service Introduction of Human Genome Sciences, Inc.

    • Table Company Profile and Development Status of Dendreon Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Inc

    • Figure Sales and Growth Rate Analysis of Dendreon Inc

    • Figure Revenue and Market Share Analysis of Dendreon Inc

    • Table Product and Service Introduction of Dendreon Inc

    • Table Company Profile and Development Status of Genentech, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc.

    • Figure Sales and Growth Rate Analysis of Genentech, Inc.

    • Figure Revenue and Market Share Analysis of Genentech, Inc.

    • Table Product and Service Introduction of Genentech, Inc.

    • Table Company Profile and Development Status of Schering-Plough Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Schering-Plough Corporation

    • Figure Sales and Growth Rate Analysis of Schering-Plough Corporation

    • Figure Revenue and Market Share Analysis of Schering-Plough Corporation

    • Table Product and Service Introduction of Schering-Plough Corporation

    • Table Company Profile and Development Status of Medarex, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medarex, Inc.

    • Figure Sales and Growth Rate Analysis of Medarex, Inc.

    • Figure Revenue and Market Share Analysis of Medarex, Inc.

    • Table Product and Service Introduction of Medarex, Inc.

    • Table Company Profile and Development Status of BD Biosciences Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD Biosciences Corporation

    • Figure Sales and Growth Rate Analysis of BD Biosciences Corporation

    • Figure Revenue and Market Share Analysis of BD Biosciences Corporation

    • Table Product and Service Introduction of BD Biosciences Corporation

    • Table Company Profile and Development Status of PDL BioPharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PDL BioPharma

    • Figure Sales and Growth Rate Analysis of PDL BioPharma

    • Figure Revenue and Market Share Analysis of PDL BioPharma

    • Table Product and Service Introduction of PDL BioPharma

    • Table Company Profile and Development Status of Biotest, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest, Inc.

    • Figure Sales and Growth Rate Analysis of Biotest, Inc.

    • Figure Revenue and Market Share Analysis of Biotest, Inc.

    • Table Product and Service Introduction of Biotest, Inc.

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of UCB Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB Group

    • Figure Sales and Growth Rate Analysis of UCB Group

    • Figure Revenue and Market Share Analysis of UCB Group

    • Table Product and Service Introduction of UCB Group

    • Table Company Profile and Development Status of MedImmune, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune, Inc.

    • Figure Sales and Growth Rate Analysis of MedImmune, Inc.

    • Figure Revenue and Market Share Analysis of MedImmune, Inc.

    • Table Product and Service Introduction of MedImmune, Inc.

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

    • Table Company Profile and Development Status of Amgen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen AG

    • Figure Sales and Growth Rate Analysis of Amgen AG

    • Figure Revenue and Market Share Analysis of Amgen AG

    • Table Product and Service Introduction of Amgen AG

    • Table Company Profile and Development Status of Elan Corporations Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elan Corporations Plc

    • Figure Sales and Growth Rate Analysis of Elan Corporations Plc

    • Figure Revenue and Market Share Analysis of Elan Corporations Plc

    • Table Product and Service Introduction of Elan Corporations Plc

    • Table Company Profile and Development Status of Wyeth Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wyeth Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Wyeth Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Wyeth Pharmaceuticals

    • Table Product and Service Introduction of Wyeth Pharmaceuticals

    • Table Company Profile and Development Status of CMC ICOS Biologics, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CMC ICOS Biologics, Inc.

    • Figure Sales and Growth Rate Analysis of CMC ICOS Biologics, Inc.

    • Figure Revenue and Market Share Analysis of CMC ICOS Biologics, Inc.

    • Table Product and Service Introduction of CMC ICOS Biologics, Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US